Viridian Therapeutics, Inc. (VRDN) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Logos Global Master Fund LP con 6,000,000 acciones. Otros tenedores destacados incluyen Fairmount Funds Management LLC y Atlas Venture Fund VII L P.
En los últimos 12 meses, los internos han realizado 25 transacciones en VRDN acciones — 12 compras (valoradas en $11.82M) y 1 ventas (valoradas en $70.8K). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
VRDN Participación de Insiders
Principal Titular
Logos Global Master Fund LP
6,000,000 acciones
Compras (12 meses)
12
$11.82M valor
Ventas (12 meses)
1
$70.8K valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Logos Global Master Fund Lp |
10 Percent Owner |
6,000,000 |
2020-11-16 |
|
| 2 |
Fairmount Funds Management Llc |
10 Percent Owner |
3,914,458 |
2025-10-27 |
|
| 3 |
Atlas Venture Fund Vii L P |
10 Percent Owner |
3,142,580 |
2017-02-13 |
|
| 4 |
Remeditex Ventures Llc |
10 Percent Owner |
2,706,563 |
2017-02-13 |
|
| 5 |
Frazier Life Sciences Public Fund, L.p. |
10 Percent Owner |
1,505,200 |
2021-09-28 |
|
| 6 |
Fairmount Healthcare Fund Ii L.p. |
Director |
1,363,764 |
2022-08-19 |
|
| 7 |
Marshall William Stuart |
President & CEO |
464,000 |
2020-02-14 |
|
| 8 |
Point72 Asset Management, L.p. |
10 Percent Owner |
426,162 |
2020-11-20 |
|
| 9 |
Ra Capital Management, L.p. |
10 Percent Owner |
410,686 |
2020-12-17 |
|
| 10 |
Leverone Jason A. |
Chief Financial Officer |
311,785 |
2021-01-20 |
|
| 11 |
Escolar Diana |
Chief Medical Officer |
270,000 |
2020-02-14 |
|
| 12 |
Myers Scott Dunseth |
Chief Executive Officer |
259,500 |
2023-04-12 |
|
| 13 |
Violin Jonathan |
Chief Executive Officer |
239,205 |
2023-02-07 |
|
| 14 |
Riccitelli Samuel D |
President & CEO |
200,000 |
2016-05-19 |
|
| 15 |
Katz Barrett |
Chief Medical Officer |
108,000 |
2023-02-10 |
|
| 16 |
Humer Kristian |
CFO and Cbo |
108,000 |
2023-02-10 |
|
| 17 |
Rubin Paul D |
EVP, Research & Development |
87,000 |
2019-02-08 |
|
| 18 |
Levy Adam Scott |
Chief Business Officer |
74,000 |
2019-02-08 |
|
| 19 |
Melvin Carrie |
COO |
54,000 |
2023-02-10 |
|
| 20 |
Ciulla Thomas |
Chief Medical Officer |
50,000 |
2024-02-07 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retención Fiscal de RSU |
1,675 |
$30.19 |
$50.57K |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retención Fiscal de RSU |
2,031 |
$30.19 |
$61.32K |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retención Fiscal de RSU |
7,408 |
$30.19 |
$223.65K |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retención Fiscal de RSU |
3,048 |
$30.19 |
$92.02K |
| 2026-03-03 |
Tousignant Jennifer |
Chief Legal Officer |
Retención Fiscal de RSU |
1,724 |
$29.32 |
$50.55K |
| 2026-03-02 |
Tousignant Jennifer |
Chief Legal Officer |
Concesión de RSU |
23,850 |
- |
- |
| 2025-03-03 |
Tousignant Jennifer |
Officer |
Desconocido |
- |
- |
- |
| 2026-03-03 |
Harmon Seth |
Chief Financial Officer |
Retención Fiscal de RSU |
2,091 |
$29.32 |
$61.31K |
| 2026-03-02 |
Harmon Seth |
Chief Financial Officer |
Concesión de RSU |
20,550 |
- |
- |
| 2025-03-03 |
Harmon Seth |
Officer |
Desconocido |
- |
- |
- |
| 2026-03-02 |
Tripuraneni Radhika |
Chief Medical Officer |
Concesión de RSU |
19,150 |
- |
- |
| 2026-03-03 |
Mahoney Stephen F. |
President and CEO |
Retención Fiscal de RSU |
7,627 |
$29.32 |
$223.62K |
| 2026-03-02 |
Mahoney Stephen F. |
President and CEO |
Concesión de RSU |
111,900 |
- |
- |
| 2026-03-03 |
Beetham Thomas W. |
Chief Operating Officer |
Retención Fiscal de RSU |
3,138 |
$29.32 |
$92.01K |
| 2026-03-02 |
Beetham Thomas W. |
Chief Operating Officer |
Concesión de RSU |
35,300 |
- |
- |
| 2025-12-31 |
Tousignant Jennifer |
Chief Legal Officer |
Venta Informativa |
2,272 |
$31.16 |
$70.8K |
| 2025-10-23 |
Fairmount Funds Management Llc |
10 Percent Owner |
Compra Informativa |
454,545 |
$22.00 |
$10M |
| 2025-07-01 |
Gheuens Sarah |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Kiselak Tomas |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Cain Christopher W. |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Moses Jennifer K. |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Ajer Jeffrey Robert |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-07-01 |
Morris Arlene |
Director |
Concesión de RSU |
21,000 |
$14.47 |
$303.87K |
| 2025-06-10 |
Fairmount Funds Management Llc |
10 Percent Owner |
Ejercicio de Opciones (Venta) |
12,500 |
$12.31 |
$153.88K |
| 2025-06-09 |
Fairmount Funds Management Llc |
10 Percent Owner |
Ejercicio de Opciones (Venta) |
1,600 |
$7.80 |
$12.48K |